Live Breaking News & Updates on Nordic Pregnancy Drug Safety Studies

Stay updated with breaking news from Nordic pregnancy drug safety studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Second-line diabetes drugs safe for babies? New study offers reassurance

Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H. Chan School of Public Health. ....

United States , Karolinska Institutet , Sonia Hern , National Institute Of Child Health , European Union Horizon , Research Council Of Norway Centres Excellence , Nordforsk Nordic Program On Health , Harvard Chan School , Harvard Chan , National Institute , Child Health , European Union , Nordforsk Nordic Program , Nordic Pregnancy Drug Safety Studies , Research Council , International Pregnancy Drug Safety Studies , Glp 1 , Gestational Diabetes , Health Care , Public Health , Type 2 Diabetes ,